semaglutide and cardiovascular GLP-1 agonists like Ozempic may reduce events by 20% Oral Semaglutide Lowers Cardiovascular Events

Emran T, Chowdhury NI, Sarker M, Bepari AK, Hossain M, Rahman GMS, Reza HM, Elsevier Masson (2021) L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta against isoproterenol-induced myocardial infarction

Anales de Pediatra (English Edition)

Many individuals using these medications describe their effects as turning off the food noise, or the constant thoughts about food that make adhering to dietary changes so difficult, particularly for those with food addictions or a history of overeating

721 A comprehensive nutrition study found that iron intake increased ischemic stroke mortality in Japanese men, 722 and higher serum ferritin levels were linked to a higher risk of ischemic stroke in type 2 diabetes patients and postmenopausal women, 723,724 suggesting that peripheral iron accumulation is a risk factor for ischemic stroke

While Ozempic is a popular brand of GLP-1 receptor agonist used for weight loss and diabetes management, GLP-1 itself refers to a class of medications with similar effects

Higher doses of semaglutide lead to greater weight loss by more strongly activating the brain regions that control appetite, resulting in reduced hunger and increased feelings of fullness